Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT), a commercial-stage biotechnology company with a market capitalization of ...

BTIG analysts began covering Arcturus Therapeutics (NASDAQ:ARCT) with a positive outlook, assigning a Buy rating and establishing a price target of $41.00. Currently trading at $16.49 with a market ...

BTIG initiated coverage of Arcturus Therapeutics (ARCT) with a Buy rating and $41 price target Arcturus is a commercial-stage biotechnology ...

Self-assembly is the process by which an organized structure spontaneously forms from individual components, as a result of specific, local interactions among the components. When the constitutive ...

A significant breakthrough in RNA therapeutics, this self-amplifying technology overcomes key challenges by incorporating alternative ... resulting in enhanced performance of a COVID-19 vaccine with ...

A significant breakthrough in RNA therapeutics, this self-amplifying technology overcomes key challenges by incorporating alternative ... resulting in enhanced performance of a COVID-19 vaccine with ...

Arcturus Therapeutics’ H5N1 pandemic influenza vaccine candidate, ARCT-2304, is a self-amplifying mRNA vaccine candidate, whose Phase I clinical trial is funded by BARDA. The randomised, ...

Navi Mumbai (Maharashtra) [India], January 13: The India Authors Conclave 2024, organized by the India Authors Academy (IAA), brought together over 150 authors from across the nation in a landmark ...

The Yarmouth town council voted unanimously this month to remove two town-owned dams on the Royal River and consider fish passage improvements at a stretch of rapids in between them, a historic ...